IP Library Granted Patent US 8,911,981
Granted Patent B2
US 8,911,981 · App. 13/838,899 · Granted Dec 16, 2014

Ketol-acid reductoisomerase using NADH

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,911,981
App. No.
13/838,899
Granted
Dec 16, 2014
Kind
B2
Abstract

Methods for the evolution of NADPH specific ketol-add reductoisomerase enzymes to acquire NADH specificity are provided. Specific mutant ketol-acid reductoisomerase enzymes isolated from Pseudomonas that have undergone co-factor switching to utilize NADH are described.

Claims (20)

1. A recombinant host cell comprising a mutant ketol-acid reductoisomerase enzyme, wherein said enzyme has a ketol-acid reductoisomerase HMM search profile E value of <10 −3 using the hmmsearch program and comprises at least one mutation within the phosphate binding loop of said enzyme wherein said at least one mutation comprises a substitution at the residue corresponding to T52 of SEQ ID NO:17 wherein the substitution at residue T52 is a substitution to a polar, negatively charged amino acid.

2. The recombinant host cell of claim 1 , wherein the recombinant host cell is a member of a genera selected from Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Vibrio, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthobacter, Corynebacterium, Brevibacterium, Pichia, Candida, Hansenula , and Saccharomyces.

3. The recombinant host cell of claim 2 , wherein the host cell is a Saccharomyces.

4. The recombinant host cell of claim 1 , wherein the mutant ketol-acid reductoisomerase enzyme comprises a GxGxx(G/A) cofactor binding motif.

5. The recombinant host cell of claim 1 , wherein the host cell further comprises an acetolactate synthase enzyme.

6. The recombinant host cell of claim 5 , wherein the acetolactate synthase enzyme is a Bacillus subtilis acetolactate synthase enzyme.

7. A method of converting acetolactate to 2,3-dihydroxyisovalerate, the method comprising:

(a) providing a recombinant host cell comprising a mutant ketol-acid reductoisomerase enzyme, wherein said enzyme has a ketol-acid reductoisomerase HMM search profile E value of <10 −3 using the hmmsearch program and comprises at least one mutation within the phosphate binding loop of said enzyme wherein said at least one mutation comprises a substitution at the residue corresponding to T52 of SEQ ID NO:17 wherein the substitution at residue T52 is a substitution to a polar, negatively charged amino acid; and

(b) contacting the recombinant host cell with acetolactate, wherein the recombinant host cell converts acetolactate to 2,3-dihydroxyisovalerate.

8. The method of claim 7 , wherein the recombinant host cell is a member of a genera selected from Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Vibrio, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthobacter, Corynebacterium, Brevibacterium, Pichia, Candida, Hansenula , and Saccharomyces.

9. The method of claim 8 , wherein the recombinant host cell is a Saccharomyces.

10. The method of claim 7 , wherein the mutant ketol-acid reductoisomerase enzyme comprises a GxGxx(G/A) cofactor binding motif.

11. A method of producing isobutanol, the method comprising:

(a) providing a recombinant host cell comprising an isobutanol biosynthetic pathway, wherein the isobutanol biosynthetic pathway comprises a mutant ketol-acid reductoisomerase enzyme, wherein the enzyme has a ketol-acid reductoisomerase HMM search profile E value of <10 −3 using the hmmsearch program and comprises at least one mutation within the phosphate binding loop of said enzyme wherein said at least one mutation comprises a substitution at the residue corresponding to T52 of SEQ ID NO:17 wherein the substitution at residue T52 is a substitution to a polar, negatively charged amino acid; and

(b) contacting the recombinant host cell with a fermentable carbon substrate, wherein the recombinant host cell produces isobutanol.

12. The method of claim 11 , wherein the recombinant host cell is a member of a genera selected from Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Vibrio, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthobacter, Corynebacterium, Brevibacterium, Pichia, Candida, Hansenula , and Saccharomyces.

13. The method of claim 12 , wherein the recombinant host cell is a Saccharomyces.

14. The method of claim 11 , wherein the mutant ketol-acid reductoisomerase enzyme comprises a GxGxx(G/A) cofactor binding motif.

15. The method of claim 11 , wherein the recombinant host cell further comprises an acetolactate synthase enzyme.

16. The method of claim 15 , wherein the acetolactate synthase enzyme is a Bacillus subtilus acetolactate synthase enzyme.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 17, 2023
From: LI, YOUGEN; LIAO, DER-ING; NELSON, MARK J.; OKEEFE, DANIEL P.
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 062400/0751 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2021
From: TOMB, JEAN-FRANCOIS
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 057305/0763 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: BUTAMAX ADVANCED BIOFUELS LLC
Reel/Frame 057299/0663 →